Cgate,EternityF (35 F)

DOB:1976-07-01 | Patient ID:150330 | Resulted Date:2011-07-30 10:52:09 | Fasting:none

Eternity Medicine Institute - Las Vegas

Test Name	Flag	Result	Unit of Measure	Reference Range	Optimal Range
Adiponectin*		4.2	ug/mL	>1.4
Alpha Fetoprotein (AFP)*		1.1	ng/mL	<15
Amphiregulin*		<320	pg/mL	<2360
Androstenedione		2.54	ng/mL	0.6 - 3.1
Anti-Nuclear Antibody*		53	AU/mL	<120
Beta-2-Glycoprotein IgG Antibody*		13	RBM Ratio	<32
Betacellulin*		463	pg/mL	<3140
Calcitonin*		<7.2	pg/mL	<14
Cancer Antigen 125 (CA 125)*		6.3	U/mL	<35
Cancer Antigen 15-3 (CA 15-3)		22.8	U/mL	<53
Cancer Antigen 19-9 (CA 19-9)*		38	U/mL	<52
Carcinoembryonic Antigen (CEA)*		1.2	ng/mL	<5
Centromere Prot B Ab		8	AU/mL	<120
Cortisol		23.5	ug/dL	2.5 - 25
C-peptide		2.01	ng/mL	<2.2
High Sensitivity C-Reactive Protein (hsCRP)*	H	>15	ug/mL	<1
Creatine Kinase-MB*		<0.91	ng/mL	<47
Dehydroepiandrosterone Sulfate		103	ug/dL	10 - 560
Double-Stranded DNA Ig Antibody*		5	IU/mL	<120
Epstein-Barr Virus Early Ag IgG Antibody*	H	113	RBM Ratio	<87
Epstein-Barr Viral Capsid Ag IgG Ab	H	91	RBM Ratio	<10
Epidermal Growth Factor*		109	pg/mL	<795
Epidermal Growth Factor Receptor		5.00	ng/mL	4.10-8.10
Epiregulin*		<30	pg/mL	<141
Estradiol		56.7	pg/mL	<57
Factor VII*		276	ng/mL	237 - 1055
Fatty Acid Binding Protein*		2.5	ng/mL	<7.6
Ferritin		198	ng/mL	28 - 365
Fibroblast Growth Factor Basic*		<13	pg/mL	<170
Folic Acid		12.4	ng/mL	>3
Follicle Stimulating Hormone		3.92	mIU/mL	1.4 - 18
Gastrin		26.9	pg/mL	<115
Glucagon-Like Peptide-1 (GLP-1)*		12	pg/mL	<15.6
Growth Hormone*		0.29	ng/mL	<9.7
Helicobacter pylori Ig Antibody*		4.6	RBM Ratio	<6
Heparin Binding EGF-Like Growth Factor*		160	pg/mL	<532
Histone Ig Antibody		24	AU/mL	<120
Homocysteine		12	umol/L	<15
Human Chorionic Gonadotropin (Beta hCG)*		<1.00	mIU/mL	<10	<5
Immunoglobulin E		27.7	IU/mL	<180
Insulin*		2	uIU/mL	<5.4
Glucose/Insulin			Ratio	>4.5
Insulin Ig Antibody*		2.3	RBM Ratio	<5
Insulin-Like Growth Factor Binding Protein 3		3.26	ug/mL	2.2 - 6.6
Insulin-Like Growth Factor-1		174	ng/mL	55 - 240
Intercellular Adhesion Molecule 1*		133	ng/mL	51 - 196
Interleukin 1-Beta*		<0.18	pg/mL	<9.2
Interleukin-6 (IL-6)*		<3.6	pg/mL	<12
Interleukin-8 (IL-8)*		13	pg/mL	<29.2
JO-1 IgG Ab		15	AU/mL	<120
Leptin*		3.7	ng/mL	<6.9
Luteinizing Hormone		2.99	mIU/mL	0.8 - 7.6
Matrix Metalloproteinase 2 (MMP2)*		<38	ng/mL	<233
Matrix Metalloproteinase 3 (MMP3)*	H	22	ng/mL	<18
Matrix Metalloproteinase 9 (MMP9)*		<8.3	ng/mL	<37
Neuron Specific Enolase (NSE)*		<21	ng/mL	<236
Pancreatic Islet Cell Ig Antibody*		2.6	RBM Ratio	<5
Pancreatic Polypeptide (PP)*		88	pg/mL	16 - 308
Parathyroid Hormone		12.8	pg/mL	<87
Placenta Growth Factor*		23	pg/mL	<181
Plasminogen Activator Inhibitor Type 1 (PAI-1		141	ng/mL	<258
Progesterone		0.738	ng/mL	<1.1
Proinsulin, Total*		<5	pmol/L	<42
Proinsulin, Intact*		<4.75	pmol/L	<8.5
Proinsulin, Split	H	33.0	pmol/L	<32.2
Proinsulin/Insulin Ratio	H	5.00	Ratio	<4.50
Prolactin		6.83	ng/mL	0.6 - 29
Prostate Specific Antigen Total (PSA)	H	4.82	ng/mL	<4
Prostate Specific Antigen Free	H	0.665	ng/mL	<0.42
% Free PSA			%	>30
Prostatic Acid Phosphatase*		1.6	ng/mL	<6.7
Resistin*		4.7	ng/mL	1.6 - 6.1
Ribosomal Nuclear Protein Ig Antibody*		28	AU/mL	<120
Scleroderma 70 Ig Antibody*		53	AU/mL	<120
Sex Hormone Binding Globulin		31.9	nmol/L	13 - 71
Smith Ig Antibody*		13	AU/mL	<120
SSA Ig Antibody*		24	AU/mL	<120
SSB Ig Antibody*		16	AU/mL	<120
Tenascin-C*	H	1220	ng/mL	<1110
Testosterone		836	ng/dL	181 - 1593
Testosterone, Free (calculated)	L	1.0	ng/dL	4.0-19.0
Note: *********************************** Please Note: When Total Testosterone <20 ng/dL, Free Testosterone is not calculated.
Testosterone Bioavailable (calculated)	L	1	ng/dL	102-469
Testosterone Percent Free (calculated)	L	1.0	ng/dL	>2.2
Thyroglobulin Antibody		<20.0	IU/mL	<40
Thyroid Microsomal Ig Antibody		<10.0	IU/mL	<35
Thyroid Stimulating Hormone (TSH)*	H	4.9	uIU/mL	0.45 - 4.1
Thyroxine Binding Globulin		15.1	ug/mL	13 - 39
Thyroxine Antibody*		2.3	RBM Ratio	<5
Tissue Factor*		<0.31	ng/mL	<2.2
Tissue Transglutaminase Ig Antibody*		3.2	RBM Ratio	<11
Transforming Growth Factor Alpha*		<10	pg/mL	<111
Triiodothyronine Ab		1.9	RBM Ratio	<5
Tumor Necrosis Factor Alpha	H	15	pg/mL	<7
Tumor Necrosis Factor Receptor (TNFR2)*		4.5	ng/mL	<10
Vascular Endothelial Growth Factor (VEGF)*	H	2160	pg/mL	439 - 2020
Vitamin B12		972	pg/mL	>181
Platelet-Derived Growth Factor BB*		23300	pg/mL	<31800
T3, Free		1.9	pg/mL	1.8-4.2
T4, Free		0.78	ng/dL	0.73-1.95

Test Name

Flag

Result

Unit of Measure

Reference Range

Optimal Range

Partial or Corrected

Test Performed By: Biophysical 7801 North Lamar #E210, Austin TX 78752 CLIA #45D2008896

Adiponectin*

4.2

ug/mL

>1.4

Alpha Fetoprotein (AFP)*

1.1

ng/mL

<15

Amphiregulin*

<320

pg/mL

<2360

Androstenedione

2.54

ng/mL

0.6 - 3.1

Anti-Nuclear Antibody*

AU/mL

<120

Beta-2-Glycoprotein IgG Antibody*

RBM Ratio

<32

Betacellulin*

463

pg/mL

<3140

Calcitonin*

<7.2

pg/mL

<14

Cancer Antigen 125 (CA 125)*

6.3

U/mL

<35

Cancer Antigen 15-3 (CA 15-3)

22.8

U/mL

<53

Cancer Antigen 19-9 (CA 19-9)*

U/mL

<52

Carcinoembryonic Antigen (CEA)*

1.2

ng/mL

Centromere Prot B Ab

AU/mL

<120

Cortisol

23.5

ug/dL

2.5 - 25

C-peptide

2.01

ng/mL

<2.2

High Sensitivity C-Reactive Protein (hsCRP)*

>15

ug/mL

Creatine Kinase-MB*

<0.91

ng/mL

<47

Dehydroepiandrosterone Sulfate

103

ug/dL

10 - 560

Double-Stranded DNA Ig Antibody*

IU/mL

<120

Epstein-Barr Virus Early Ag IgG Antibody*

113

RBM Ratio

<87

Epstein-Barr Viral Capsid Ag IgG Ab

RBM Ratio

<10

Epidermal Growth Factor*

109

pg/mL

<795

Epidermal Growth Factor Receptor

5.00

ng/mL

4.10-8.10

Epiregulin*

<30

pg/mL

<141

Estradiol

56.7

pg/mL

<57

Factor VII*

276

ng/mL

237 - 1055

Fatty Acid Binding Protein*

2.5

ng/mL

<7.6

Ferritin

198

ng/mL

28 - 365

Fibroblast Growth Factor Basic*

<13

pg/mL

<170

Folic Acid

12.4

ng/mL

Follicle Stimulating Hormone

3.92

mIU/mL

1.4 - 18

Gastrin

26.9

pg/mL

<115

Glucagon-Like Peptide-1 (GLP-1)*

pg/mL

<15.6

Growth Hormone*

0.29

ng/mL

<9.7

Helicobacter pylori Ig Antibody*

4.6

RBM Ratio

Heparin Binding EGF-Like Growth Factor*

160

pg/mL

<532

Histone Ig Antibody

AU/mL

<120

Homocysteine

umol/L

<15

Human Chorionic Gonadotropin (Beta hCG)*

<1.00

mIU/mL

<10

Immunoglobulin E

27.7

IU/mL

<180

Insulin*

uIU/mL

<5.4

Glucose/Insulin

Ratio

>4.5

Insulin Ig Antibody*

2.3

RBM Ratio

Insulin-Like Growth Factor Binding Protein 3

3.26

ug/mL

2.2 - 6.6

Insulin-Like Growth Factor-1

174

ng/mL

55 - 240

Intercellular Adhesion Molecule 1*

133

ng/mL

51 - 196

Interleukin 1-Beta*

<0.18

pg/mL

<9.2

Interleukin-6 (IL-6)*

<3.6

pg/mL

<12

Interleukin-8 (IL-8)*

pg/mL

<29.2

JO-1 IgG Ab

AU/mL

<120

Leptin*

3.7

ng/mL

<6.9

Luteinizing Hormone

2.99

mIU/mL

0.8 - 7.6

Matrix Metalloproteinase 2 (MMP2)*

<38

ng/mL

<233

Matrix Metalloproteinase 3 (MMP3)*

ng/mL

<18

Matrix Metalloproteinase 9 (MMP9)*

<8.3

ng/mL

<37

Neuron Specific Enolase (NSE)*

<21

ng/mL

<236

Pancreatic Islet Cell Ig Antibody*

2.6

RBM Ratio

Pancreatic Polypeptide (PP)*

pg/mL

16 - 308

Parathyroid Hormone

12.8

pg/mL

<87

Placenta Growth Factor*

pg/mL

<181

Plasminogen Activator Inhibitor Type 1 (PAI-1

141

ng/mL

<258

Progesterone

0.738

ng/mL

<1.1

Proinsulin, Total*

pmol/L

<42

Proinsulin, Intact*

<4.75

pmol/L

<8.5

Proinsulin, Split

33.0

pmol/L

<32.2

Proinsulin/Insulin Ratio

5.00

Ratio

<4.50

Prolactin

6.83

ng/mL

0.6 - 29

Prostate Specific Antigen Total (PSA)

4.82

ng/mL

Prostate Specific Antigen Free

0.665

ng/mL

<0.42

% Free PSA

>30

Prostatic Acid Phosphatase*

1.6

ng/mL

<6.7

Resistin*

4.7

ng/mL

1.6 - 6.1

Ribosomal Nuclear Protein Ig Antibody*

AU/mL

<120

Scleroderma 70 Ig Antibody*

AU/mL

<120

Sex Hormone Binding Globulin

31.9

nmol/L

13 - 71

Smith Ig Antibody*

AU/mL

<120

SSA Ig Antibody*

AU/mL

<120

SSB Ig Antibody*

AU/mL

<120

Tenascin-C*

1220

ng/mL

<1110

Testosterone

836

ng/dL

181 - 1593

Testosterone, Free (calculated)

1.0

ng/dL

4.0-19.0

Note:

***********************************
Please Note: When Total Testosterone <20 ng/dL, Free Testosterone is not calculated.

Testosterone Bioavailable (calculated)

ng/dL

102-469

Testosterone Percent Free (calculated)

1.0

ng/dL

>2.2

Thyroglobulin Antibody

<20.0

IU/mL

<40

Thyroid Microsomal Ig Antibody

<10.0

IU/mL

<35

Thyroid Stimulating Hormone (TSH)*

4.9

uIU/mL

0.45 - 4.1

Thyroxine Binding Globulin

15.1

ug/mL

13 - 39

Thyroxine Antibody*

2.3

RBM Ratio

Tissue Factor*

<0.31

ng/mL

<2.2

Tissue Transglutaminase Ig Antibody*

3.2

RBM Ratio

<11

Transforming Growth Factor Alpha*

<10

pg/mL

<111

Triiodothyronine Ab

1.9

RBM Ratio

Tumor Necrosis Factor Alpha

pg/mL

Tumor Necrosis Factor Receptor (TNFR2)*

4.5

ng/mL

<10

Vascular Endothelial Growth Factor (VEGF)*

2160

pg/mL

439 - 2020

Vitamin B12

972

pg/mL

>181

Platelet-Derived Growth Factor BB*

23300

pg/mL

<31800

T3, Free

1.9

pg/mL

1.8-4.2

T4, Free

0.78

ng/dL

0.73-1.95

Test Name	Flag	Result	Unit of Measure	Reference Range
Glucose		98	MG/DL	65-100
BUN		19	MG/DL	8-25
Creatinine		0.8	MG/DL	0.8-1.4
eGFR African American		127	ML/MIN/1.7	>60
eGFR Non-African American		105	ML/MIN/1.7	>60
BUN/Creatinine (Calc)		24		6-28
Sodium		138	MEQ/L	133-146
Potassium		4.5	MEQ/L	3.5-5.3
Chloride		110	MEQ/L	97-110
Carbon Dioxide		18	MEQ/L	18-30
Calcium		10.5	MG/DL	8.5-10.5
Protein, Total		7.5	G/DL	6.0-8.4
Albumin		4.1	G/DL	2.9-5.0
Globulin (Calc)		3.4	G/DL	2.0-3.8
A/G Ratio (Calc)		1.2		0.9-2.5
Bilirubin, Total		0.5	MG/DL	0.1-1.3
Alkaline Phosphatase		65	U/L	30-132
SGOT (AST)		21	U/L	5-35
SGPT (ALT)		15	U/L	7-56
WBC		10.6	K/UL	4.0-11.0
RBC		4.25	M/UL	4.10-5.70
Hemoglobin		15.1	G/DL	13.0-17.0
Hematocrit		42.9	%	37.0-49.0
MCV		98.2	fL	80.0-100.0
MCH		33.1	PG	27.0-34.0
MCHC		32.8	G/DL	32.0-35.5
RDW		13.6	%	11.0-15.0
Neutrophil Percentage		70	%	40-74
Neutrophil Count	H	7.4	K/UL	1.8-7.0
Lymphocyte Percentage		20	%	19-48
Lymphocyte Count		2.1	K/UL	1.0-4.8
Monocyte Percentage		5	%	4-13
Monocyte Count		0.5	K/UL	0.0-0.8
Eosinophil Percentage		4	%	0-7
Eosinophil Count		0.4	K/UL	0.0-0.5
Basophil Percentage		1	%	0-2
Basophil Count		0.1	K/UL	0.0-0.2
Platelet Count		325	K/UL	130-400
Hemoglobin A1c	H	5.8	%	4.0-5.6
Amylase		100	U/L	30-120
Iron, Serum		75	UG/DL	35-158
Iron Binding Capacity, Unsaturated		220	UG/DL	155-300
Iron Binding Capacity, Total (Calc)		295	UG/DL	250-450
% Iron Saturated (Calc)		25	%	20-50
GGT		55	U/L	7-70
Uric Acid		7.2	MG/DL	3.3-8.5
LDH		101	U/L	60-270
CK Total		228	U/L	37-289
Hepatitis A Total Ab		NEGATIVE		NEGATIVE
Hepatitis A IgM		NOT INDICATED		NEGATIVE
Interpretation Hepatitis A:		(NOTE)
Note: Hepatitis A serology shows no evidence of past exposure to or current infection with hepatitis A virus; patient not immune to hepatitis A.
Hepatitis B Surface Ag		NEGATIVE		NEGATIVE
Hep B Core Total Ab		NEGATIVE		NEGATIVE
Hepatitis B Surface Ab		NEGATIVE		NEGATIVE
Interpretation Hepatits B:		(NOTE)
Note: Hepatitis B serology shows no evidence of past exposure to or current infection with hepatitis B virus.
Hepatitis C Ab		NEGATIVE		NEGATIVE
Interpretation Hepatitis C:		(NOTE)
Note: Hepatitis C serology shows no serologic evidence of exposure to hepatitis C virus at this time. It can take up to 12 months after exposure to the hepatitis C virus for antibodies to become detectable in the blood.
EBV VCA IgG		15.2	U/ML	SEE BELOW
Note: EBV VCA IgG INTERPRETATION: NEGATIVE <18.0 U/ML EQUIVOCAL 18.0-21.9 U/ML POSITIVE >/=22.0 U/ML
EBV VCA IgM		30.5	U/ML	SEE BELOW
Note: EBV VCA IgM INTERPRETATION: NEGATIVE <36.0 U/ML EQUIVOCAL 36.0-43.9 U/ML POSITIVE >/=44.0 U/ML
Immunoglobulin A (IgA)		224	MG/DL	69-382
Immunoglobulin M (IgM)		112	MG/DL	63-277
Magnesium		2.0	MG/DL	1.3-2.3
Phosphorus		3.2	MG/DL	2.2-4.5
Rheumatoid Factor, Quant		20	IU/ML	<30
Vitamin D, 25 OH		62	NG/ML	30-100
Note: NOTE: 25-HYDROXYVITAMIN D ASSAY INCLUDES 25-HYDROXYVITAMIN D2 AND D3. METHODOLOGY IS CHEMILUMINESCENT IMMUNOASSAY. *** INTERPRETIVE RANGES *** INSUFFICIENT . . . . . . . . . . . . . . . . <20 NG/ML SUBOPTIMAL . . . . . . . . . . . . . . . . . 20 - 29 NG/ML OPTIMAL. . . . . . . . . . . . . . . . . . . 30 - 100 NG/ML POSSIBLE TOXICITY. . . . . . . . . . . . . . >100 NG/ML UNLESS OTHERWISE INDICATED, ALL TESTING PERFORMED AT CLINICAL PATHOLOGY LABORATORIES, INC. 9200 WALL ST AUSTIN, TX 78754 LABORATORY DIRECTOR: MARK A. SILBERMAN, M.D. CLIA NUMBER 45D0505003 CAP ACCREDITATION NO. 21525-01

Test Name

Flag

Result

Unit of Measure

Reference Range

Optimal Range

Partial or Corrected

Test Performed By: Clinical Pathology Laboratories, Inc. 9200 Wall Street, Austin TX 78754 CLIA #45D0505003

Glucose

MG/DL

65-100

BUN

MG/DL

8-25

Creatinine

0.8

MG/DL

0.8-1.4

eGFR African American

127

ML/MIN/1.7

>60

eGFR Non-African American

105

ML/MIN/1.7

>60

BUN/Creatinine (Calc)

6-28

Sodium

138

MEQ/L

133-146

Potassium

4.5

MEQ/L

3.5-5.3

Chloride

110

MEQ/L

97-110

Carbon Dioxide

MEQ/L

18-30

Calcium

10.5

MG/DL

8.5-10.5

Protein, Total

7.5

G/DL

6.0-8.4

Albumin

4.1

G/DL

2.9-5.0

Globulin (Calc)

3.4

G/DL

2.0-3.8

A/G Ratio (Calc)

1.2

0.9-2.5

Bilirubin, Total

0.5

MG/DL

0.1-1.3

Alkaline Phosphatase

U/L

30-132

SGOT (AST)

U/L

5-35

SGPT (ALT)

U/L

7-56

WBC

10.6

K/UL

4.0-11.0

RBC

4.25

M/UL

4.10-5.70

Hemoglobin

15.1

G/DL

13.0-17.0

Hematocrit

42.9

37.0-49.0

MCV

98.2

80.0-100.0

MCH

33.1

27.0-34.0

MCHC

32.8

G/DL

32.0-35.5

RDW

13.6

11.0-15.0

Neutrophil Percentage

40-74

Neutrophil Count

7.4

K/UL

1.8-7.0

Lymphocyte Percentage

19-48

Lymphocyte Count

2.1

K/UL

1.0-4.8

Monocyte Percentage

4-13

Monocyte Count

0.5

K/UL

0.0-0.8

Eosinophil Percentage

0-7

Eosinophil Count

0.4

K/UL

0.0-0.5

Basophil Percentage

0-2

Basophil Count

0.1

K/UL

0.0-0.2

Platelet Count

325

K/UL

130-400

Hemoglobin A1c

5.8

4.0-5.6

Amylase

100

U/L

30-120

Iron, Serum

UG/DL

35-158

Iron Binding Capacity, Unsaturated

220

UG/DL

155-300

Iron Binding Capacity, Total (Calc)

295

UG/DL

250-450

% Iron Saturated (Calc)

20-50

GGT

U/L

7-70

Uric Acid

7.2

MG/DL

3.3-8.5

LDH

101

U/L

60-270

CK Total

228

U/L

37-289

Hepatitis A Total Ab

NEGATIVE

Hepatitis A IgM

NOT INDICATED

NEGATIVE

Interpretation Hepatitis A:

(NOTE)

Note:

Hepatitis A serology shows no evidence of past exposure to or
current infection with hepatitis A virus; patient not immune to
hepatitis A.

Hepatitis B Surface Ag

NEGATIVE

Hep B Core Total Ab

NEGATIVE

Hepatitis B Surface Ab

NEGATIVE

Interpretation Hepatits B:

(NOTE)

Note:

Hepatitis B serology shows no evidence of past exposure to or
current infection with hepatitis B virus.

Hepatitis C Ab

NEGATIVE

Interpretation Hepatitis C:

(NOTE)

Note:

Hepatitis C serology shows no serologic evidence of exposure to
hepatitis C virus at this time. It can take up to 12 months after
exposure to the hepatitis C virus for antibodies to become detectable
in the blood.

EBV VCA IgG

15.2

U/ML

SEE BELOW

Note:

EBV VCA IgG INTERPRETATION:
NEGATIVE <18.0 U/ML
EQUIVOCAL 18.0-21.9 U/ML
POSITIVE >/=22.0 U/ML

EBV VCA IgM

30.5

U/ML

SEE BELOW

Note:

EBV VCA IgM INTERPRETATION:
NEGATIVE <36.0 U/ML
EQUIVOCAL 36.0-43.9 U/ML
POSITIVE >/=44.0 U/ML

Immunoglobulin A (IgA)

224

MG/DL

69-382

Immunoglobulin M (IgM)

112

MG/DL

63-277

Magnesium

2.0

MG/DL

1.3-2.3

Phosphorus

3.2

MG/DL

2.2-4.5

Rheumatoid Factor, Quant

IU/ML

<30

Vitamin D, 25 OH

NG/ML

30-100

Note:

NOTE: 25-HYDROXYVITAMIN D ASSAY INCLUDES 25-HYDROXYVITAMIN D2 AND
D3. METHODOLOGY IS CHEMILUMINESCENT IMMUNOASSAY.

***** INTERPRETIVE RANGES *****
INSUFFICIENT . . . . . . . . . . . . . . . . <20 NG/ML
SUBOPTIMAL . . . . . . . . . . . . . . . . . 20 - 29 NG/ML
OPTIMAL. . . . . . . . . . . . . . . . . . . 30 - 100 NG/ML
POSSIBLE TOXICITY. . . . . . . . . . . . . . >100 NG/ML

UNLESS OTHERWISE INDICATED, ALL TESTING PERFORMED AT
CLINICAL PATHOLOGY LABORATORIES, INC. 9200 WALL ST AUSTIN, TX 78754
LABORATORY DIRECTOR: MARK A. SILBERMAN, M.D.
CLIA NUMBER 45D0505003 CAP ACCREDITATION NO. 21525-01

Test Name	Flag	Result	Unit of Measure	Reference Range
Apolipoprotein A1		161	mg/dL	>118
Total Cholesterol	H	243	mg/dL	<200
Total HDL		56	mg/dL	>=40
Lipoprotein (a)	H	15.0	mg/dL	<10
Total LDL	H	162	mg/dL	<130
Triglycerides		141	mg/dL	<150
LDL Real (LDL-R)	H	128	mg/dL	<100
IDL Cholesterol		19	mg/dL	<20
HDL2		13	mg/dL	>10
HDL3		43	mg/dL	>30
Total VLDL		24	mg/dL	<30
VLDL1+2		9.8	mg/dL	<20
VLDL3	H	15	mg/dL	<10
Non-HDL Cholesterol	H	187	mg/dL	<160
Remnant Lipoproteins	H	34	mg/dL	<30
LDL Density (Pattern)	A	A/B		A
Apo B100	H	125	mg/dL	<109
Apo B100/Apo A1 Ratio		0.78		<0.92
LDL4		23.7	mg/dL
LDL3		56.6	mg/dL
LDL2		22.3	mg/dL
LDL1		25.4	mg/dL
LDL/HDL Ratio (Calc)			Ratio	<4
Cholesterol/HDL Ratio (Calc)			Ratio	<5.0

Test Name

Flag

Result

Unit of Measure

Reference Range

Optimal Range

Partial or Corrected

Test Performed By: Atherotech 201 London Parkway, Birmingham AL 35211 CLIA #01D0641541

Apolipoprotein A1

161

mg/dL

>118

Total Cholesterol

243

mg/dL

<200

Total HDL

mg/dL

>=40

Lipoprotein (a)

15.0

mg/dL

<10

Total LDL

162

mg/dL

<130

Triglycerides

141

mg/dL

<150

LDL Real (LDL-R)

128

mg/dL

<100

IDL Cholesterol

mg/dL

<20

HDL2

mg/dL

>10

HDL3

mg/dL

>30

Total VLDL

mg/dL

<30

VLDL1+2

9.8

mg/dL

<20

VLDL3

mg/dL

<10

Non-HDL Cholesterol

187

mg/dL

<160

Remnant Lipoproteins

mg/dL

<30

LDL Density (Pattern)

A/B

Apo B100

125

mg/dL

<109

Apo B100/Apo A1 Ratio

0.78

<0.92

LDL4

23.7

mg/dL

LDL3

56.6

mg/dL

LDL2

22.3

mg/dL

LDL1

25.4

mg/dL

LDL/HDL Ratio (Calc)

Ratio

Cholesterol/HDL Ratio (Calc)

Ratio

<5.0

Test Name	Flag	Result	Unit of Measure	Reference Range
Alpha Linolenic Acid (ALA)		0.24	wt%	>0.09
Eicosapentaenoic Acid (EPA)		2.0	wt%	>0.2
Docosapentaenoic Acid (DPA)		3.79	wt%	>1.14
Docosahexaenoic Acid (DHA)		7.7	wt%	>2.1
Omega-3 Index		9.7	wt%	>4.0
Percent Omega-3		13.8	%	>3.8
Linoleic Acid	L	7.8	wt%	10.5-16.9
Gamma-Linolenic Acid	H	0.17	wt%	0.03-0.13
Dihomo-Gamma-Linolenic Acid (DGLA)		1.59	wt%	>1.19
Arachidonic Acid (AA)		20	wt%	15-21
Docosatetraenoic Acid		2.27	wt%	1.50-4.20
Eicosadienoic Acid	H	0.28	wt%	<0.26
Percent Omega-6		32.2	%	30.5-39.7
Oleic Acid		11	wt%	10-13
Nervonic Acid	H	3.8	wt%	2.1-3.5
Percent Omega-9	H	32.2	%	13.3-16.6
Elaidic Acid		0.19	wt%	<0.59
Palmitoleic Acid	H	0.71	wt%	<0.64
Vaccenic Acid		0.73	wt%	<1.13
Pentadecanoic Acid		0.07	wt%	0.07-0.15
Palmitic Acid		18	wt%	18-23
Margaric Acid	L	0.21	wt%	0.22-0.37
Stearic Acid		15	wt%	14-17
Arachidic Acid		0.26	wt%	0.22-0.35
Behenic Acid	L	0.84	wt%	0.92-1.68
Tricosanoic Acid	H	0.19	wt%	0.12-0.18
Lignoceric Acid		2.9	wt%	2.1-3.8
Percent Saturated Fatty Acids	L	37.1	%	39.8-43.6
Omega-6s/Omega-3s	L	2.33	Ratio	3.40-10.70
Arachidonic Acid/Eicosapentaenoic Acid	L	9.80	Ratio	12.00-125.00
Arachidonic Acid/Dihomo-Gamma-Linolenic Acid		12.58	Ratio	7.30-15.80
1/Dihomo-Gamma-Linolenic Acid		0.63	wt%	<0.84
1/Eicosapentaenoic Acid		0.49	wt%	<6.11
Inflammation Index		1		<3
Saturated/Polyunsaturated Fats	L	0.89	Ratio	0.99-1.16
Lignoceric Acid + Nervonic Acid		6.7	wt%	4.3-7.0
Percent Omega-7		1.44	%	<1.72
1/Docosahexaenoic Acid		0.13	wt%	<0.50
Linoleic Acid/Dihomo-Gamma-Linolenic Acid	L	4.91	Ratio	6.00-12.30
Eicosadienoic Acid/Dihomo-Gamma-Linolenic Aci	H	0.18	Ratio	0.08-0.16
Dihomo-Gamma-Linolenic Acid/Arachidonic Acid		7.95	Ratio	6.30-13.70
Oleic Acid/Steric Acid		0.73	Ratio	0.60-0.90
Elaidic Acid/Oleic Acid		0.02	Ratio	<0.05
Linoleic Acid/(Arachidonic Acid+Dihomo-Gamma-	L	0.36	Ratio	0.51-1.01

Test Name

Flag

Result

Unit of Measure

Reference Range

Optimal Range

Partial or Corrected

Test Performed By: Genova Diagnostics 63 Zillicoa Street, Asheville NC 28801 CLIA #34D0655571

Alpha Linolenic Acid (ALA)

0.24

wt%

>0.09

Eicosapentaenoic Acid (EPA)

2.0

wt%

>0.2

Docosapentaenoic Acid (DPA)

3.79

wt%

>1.14

Docosahexaenoic Acid (DHA)

7.7

wt%

>2.1

Omega-3 Index

9.7

wt%

>4.0

Percent Omega-3

13.8

>3.8

Linoleic Acid

7.8

wt%

10.5-16.9

Gamma-Linolenic Acid

0.17

wt%

0.03-0.13

Dihomo-Gamma-Linolenic Acid (DGLA)

1.59

wt%

>1.19

Arachidonic Acid (AA)

wt%

15-21

Docosatetraenoic Acid

2.27

wt%

1.50-4.20

Eicosadienoic Acid

0.28

wt%

<0.26

Percent Omega-6

32.2

30.5-39.7

Oleic Acid

wt%

10-13

Nervonic Acid

3.8

wt%

2.1-3.5

Percent Omega-9

32.2

13.3-16.6

Elaidic Acid

0.19

wt%

<0.59

Palmitoleic Acid

0.71

wt%

<0.64

Vaccenic Acid

0.73

wt%

<1.13

Pentadecanoic Acid

0.07

wt%

0.07-0.15

Palmitic Acid

wt%

18-23

Margaric Acid

0.21

wt%

0.22-0.37

Stearic Acid

wt%

14-17

Arachidic Acid

0.26

wt%

0.22-0.35

Behenic Acid

0.84

wt%

0.92-1.68

Tricosanoic Acid

0.19

wt%

0.12-0.18

Lignoceric Acid

2.9

wt%

2.1-3.8

Percent Saturated Fatty Acids

37.1

39.8-43.6

Omega-6s/Omega-3s

2.33

Ratio

3.40-10.70

Arachidonic Acid/Eicosapentaenoic Acid

9.80

Ratio

12.00-125.00

Arachidonic Acid/Dihomo-Gamma-Linolenic Acid

12.58

Ratio

7.30-15.80

1/Dihomo-Gamma-Linolenic Acid

0.63

wt%

<0.84

1/Eicosapentaenoic Acid

0.49

wt%

<6.11

Inflammation Index

Saturated/Polyunsaturated Fats

0.89

Ratio

0.99-1.16

Lignoceric Acid + Nervonic Acid

6.7

wt%

4.3-7.0

Percent Omega-7

1.44

<1.72

1/Docosahexaenoic Acid

0.13

wt%

<0.50

Linoleic Acid/Dihomo-Gamma-Linolenic Acid

4.91

Ratio

6.00-12.30

Eicosadienoic Acid/Dihomo-Gamma-Linolenic Aci

0.18

Ratio

0.08-0.16

Dihomo-Gamma-Linolenic Acid/Arachidonic Acid

7.95

Ratio

6.30-13.70

Oleic Acid/Steric Acid

0.73

Ratio

0.60-0.90

Elaidic Acid/Oleic Acid

0.02

Ratio

<0.05

Linoleic Acid/(Arachidonic Acid+Dihomo-Gamma-

0.36

Ratio

0.51-1.01

* Indicates that this test uses a kit designated by the manufacturer as "for research use, not clinical use." The performance characteristics of this test were validated by the performing laboratory. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. The performing laboratory is authorized under Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity testing.